ArticleClinical drug investigation2019

Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites.

Yoshitaka Arase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.